<DOC>
	<DOCNO>NCT00297206</DOCNO>
	<brief_summary>Limited data available valaciclovir use child valaciclovir currently approve use pediatrics . The marketed formulation valaciclovir ideal use pre-adolescent patient may trouble swallow solid oral dosage form . An extemporaneous suspension formulation valaciclovir develop expedite provision benefit child similar administration valaciclovir solid formulation adult .</brief_summary>
	<brief_title>A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children</brief_title>
	<detailed_description />
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion criterion : Subjects current herpes virus infection . Have neonatally acquire herpes risk potential recurrence . Immunocompromised cancer patient risk development herpes virus infection . Exclusion criterion : Hypersensitivity antiherpetic medication . Impaired hepatic renal function . Show presence serious unstable underlying disease .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus</keyword>
</DOC>